The world's first mRNA vaccine against a deadly disease

Published Date: 15 Mar 2023

A world first: A research team from Tel Aviv University and the Israel Institute of Biology has developed an anti-mRNA drug that is 100% effective against a single type of virus.

Read Full News

Latest News

Normal Ultrasound Does Not Rule Out Term Risk

Despite detecting most severely small foetuses at the scan between 35 and 36 weeks, most stillbirths and serious neonatal complications still arise in foetuses that appear normal on ultrasound.

IgAn Diagnostic and Therapeutic Strategies

Explore how updated KDIGO IgAN guidelines, earlier biopsy driven risk stratification, and new targeted therapies (budesonide, sparsentan, complement/APRIL inhibitors) are reshaping long term outcomes.

Measles Cases in South Carolina Rise by One to 997, State Health Department Says

Measles cases in South Carolina surged to 997 on Tuesday, ⁠state health data showed, including one additional infection since Friday.

Change Healthcare Breach Still Affecting Docs, Hospitals

Physicians and hospitals alike are still digging out financially from the impact of the massive Change Healthcare hack in 2024.

Peanut Introduction Kits Encourage Earlier Peanut Feeding

Peanut kits given in pediatric clinics were linked to a threefold increase in caregivers introducing the legume 2 months later.

Which Allergens Trigger Contact Dermatitis in HCPs?

Occupational contact dermatitis affects North American healthcare workers and is commonly linked to glove rubber accelerators, surfactants, and preservatives, a retrospective study finds.

Todays Updates

Older Adults With Advanced Cancer Prioritize Quality of Life

Most older adults with advanced cancer value quality of life over extending survival, but that preference may not translate to clinical care or outcomes.

Todays Updates

Older Adults With Advanced Cancer Prioritize Quality of Life

Most older adults with advanced cancer value quality of life over extending survival, but that preference may not translate to clinical care or outcomes.

Latest News

Despite detecting most severely small foetuses at the scan between 35 and 36 weeks, most stillbirths and serious neonatal complications still arise in foetuses that appear normal on ultrasound.

Explore how updated KDIGO IgAN guidelines, earlier biopsy driven risk stratification, and new targeted therapies (budesonide, sparsentan, complement/APRIL inhibitors) are reshaping long term outcomes.

Measles cases in South Carolina surged to 997 on Tuesday, ⁠state health data showed, including one additional infection since Friday.

Physicians and hospitals alike are still digging out financially from the impact of the massive Change Healthcare hack in 2024.

Peanut kits given in pediatric clinics were linked to a threefold increase in caregivers introducing the legume 2 months later.

Occupational contact dermatitis affects North American healthcare workers and is commonly linked to glove rubber accelerators, surfactants, and preservatives, a retrospective study finds.

News All Time

Roflumilast Effective, Safe for AD in Children Over 56 weeks

Roflumilast cream 0.05% provides durable efficacy and is well-tolerated for up to 56 weeks in children aged 2-5 years with mild-to-moderate atopic dermatitis, a study finds.

Carrageenan: Allergen for Patients With Alpha Gal?

Many people with alpha-gal syndrome may be unaware of the allergenicity of the common food and drug additive.

Omalizumab Enables Safe Allergenic Food Introduction in Kids

Omalizumab treatment allows most children with immunoglobulin E-mediated food allergy to complete oral food challenges and undergo dietary introduction.

Canadians at High Risk From COVID Remain Heavily Burdened

Despite a high degree of worry about COVID and experience with severe, long-lasting symptoms, high-risk patients often do not know how to get tested or receive treatment.

Morphine Plus Acetaminophen May Boost Pain Relief in the ED

Intravenous morphine plus acetaminophen provides greater early pain reduction and requires fewer rescue doses than morphine alone in the emergency department, a trial finds.

Albumin Replacement Therapy Shows No Benefit in Septic Shock

Albumin replacement therapy targeting serum levels ≥ 3.0 g/dL does not improve 90-day survival in patients with septic shock in the emergency department, a trial shows.

Mar 13 2026 This Week in Cardiology

Beta-blocker in non-obstructive hypertrophic cardiomyopathy, a head-to-head apixaban vs rivaroxaban RCT, diltiazem vs metoprolol combined with DOAC, and the accuracy of smart watches for AF are the topics John Mandrola, MD, discusses in this week’s podcast.

How a Mom Uncovered a Hidden Driver of Childhood Eczema

New research reveals a clue in the persistent mystery of why eczema is so common in infancy.

The Unexpected Impact of TV Doctors on Patient Trust

From Dr Greene’s hubris to House’s Vicodin addiction to the traumatized doctors in The Pitt, could modern depictions of flawed physicians be doing more harm than good?

Lancet Commission Elevates Global Dermatology Priorities

For the first time, a Lancet Commission is shining a light on the global burden of skin diseases and spurring an action plan.

Does Vitiligo Raise Risk for Mental Health Disorders?

A retrospective study shows that patients with vitiligo face a high burden of mental health disorders, with the morbidity profile matching that of atopic dermatitis but not psoriasis.

SLIT Appears Safe and Effective for Dust Mite Allergy

House dust mite sublingual immunotherapy reduces symptoms, decreases medication use, and shows a favorable safety profile in adults and adolescents with allergic rhinoconjunctivitis.

Obinutuzumab Lowers Lupus Disease Activity in Phase 3 Trial

Phase 3 trial data show that obinutuzumab significantly reduces disease activity in very active extrarenal lupus.

Measles Cases in South Carolina Rise by 2 to 993, State Health Department Says

Measles cases in South Carolina rose to 993 on Tuesday, state health ⁠data showed, including two cases since the last update on Friday.

Shingles Vaccine Safe in Patients With Rheumatic Diseases

A herpes zoster vaccine is safe in adults with autoimmune rheumatic disease and elicits a strong immune response, but responses are weaker in those on rituximab or mycophenolate, per a phase 4 study.

Skin Inflammation Therapies Might Target Depression

Anti-inflammatory therapies that are highly effective for inflammatory skin diseases might also be relevant to depression because of shared inflammatory pathways.